{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T17:23:27Z","timestamp":1794590607319,"version":"4.9.1"},"reference-count":42,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi260429-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Surveillance of postacute sequelae of SARS-CoV-2 infection (PASC) depends on diagnostic coding systems that capture fewer than one-half of affected individuals, rendering millions invisible to health systems and policymakers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260429-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To quantify the gap between true PASC burden and diagnostic code\u2013based estimates, determine the proportion representing chronic disease, and characterize organ system heterogeneity and temporal trends across diverse populations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260429-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This retrospective cohort study used electronic health record data from 58 hospitals and affiliated clinics in 4 US regions, from 2017 to 2025. Adults (aged \u226518 years) with laboratory-confirmed SARS-CoV-2 infection or a COVID-19 diagnosis code were included. A custom artificial intelligence algorithm, the Precision Phenotyping for Research Cohorts (P2RC), was implemented using federated infrastructure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260429-7\">\n                    <jats:title>Exposure<\/jats:title>\n                    <jats:p>Laboratory-confirmed SARS-CoV-2 infection or COVID-19 diagnosis code.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260429-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>\n                      The primary outcomes were PASC prevalence, the proportion classified as chronic conditions, organ system distribution, and temporal trends from 2020 to 2024. \u03c7\n                      <jats:sup>2<\/jats:sup>\n                      Tests were used to assess organ system heterogeneity across regions, and negative binomial regression was used to model quarterly temporal trends, yielding incidence rate ratios (IRRs) with 95% CIs.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260429-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In this cohort study of 457\u202f950 COVID-19 cases (mean age, 52.05 years; 275\u202f107 [60.07%] female), the P2RC algorithm identified 74\u202f560 PASC cases (16.28% overall; 28\u202f585 [18.58%] in New England, 978 [19.55%] in Southeast Texas, 10\u202f534 [22.69%] in Southern California, and 34\u202f463 [13.64%] in Western Pennsylvania), more than 2-fold higher than the proportion identified by code-based surveillance (&amp;amp;lt;7%). Of 883\n                      <jats:italic toggle=\"yes\">International Statistical Classification of Diseases, Tenth Revision, Clinical Modification<\/jats:italic>\n                      codes associated with PASC, 594 (67.27%) represented chronic or potentially chronic conditions. Of 74\u202f560 patients with PASC, 66\u202f587 (89.31%) developed chronic conditions requiring ongoing clinical management; this represents 14.54% of the total number of 457\u202f950 patients with COVID-19. Substantial organ system heterogeneity was observed (\u03c7\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u20092504.73;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001): New England demonstrated thyroid-predominant endocrine patterns, while Southeast Texas, Southern California, and Western Pennsylvania showed metabolic-predominant profiles. Negative binomial regression revealed increasing PASC prevalence through mid-2024 (IRR per quarter, 1.01 [95% CI, 1.00-1.01;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001] in New England; 1.00 [95% CI, 1.00-1.01;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001] in Southern California; and 1.02 [95% CI, 1.01-1.02;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001] in Western Pennsylvania), indicating an accumulating rather than resolving burden.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260429-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this cohort study, approximately 1 in 6 patients with COVID-19 developed PASC, and 89.31% of these patients had at least 1 chronic condition. Current diagnostic coding captured fewer than one-half of the cases, obscuring a substantial chronic disease burden. The persistently increasing prevalence through 2024 indicated an accumulating health care burden requiring investment in surveillance infrastructure and integrated care pathways.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.14909","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T15:30:31Z","timestamp":1779895831000},"page":"e2614909","source":"Crossref","is-referenced-by-count":6,"title":["Long COVID Persistence and Surveillance Gaps Across 58 US Hospitals"],"prefix":"10.1001","volume":"9","author":[{"given":"Jiazi","family":"Tian","sequence":"first","affiliation":[{"name":"Department of Medicine, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaleh","family":"Azhir","sequence":"additional","affiliation":[{"name":"Department of Medicine, Massachusetts General Hospital, Boston"},{"name":"Department of Medicine, Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Decaro","sequence":"additional","affiliation":[{"name":"D. Bradley McWilliams School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ngan","family":"Chau","sequence":"additional","affiliation":[{"name":"CTSI\/Biomedical Informatics Program, University of California, Los Angeles, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"H\u00fcgel","sequence":"additional","affiliation":[{"name":"Department of Medicine, Massachusetts General Hospital, Boston"},{"name":"University Medical Center G\u00f6ttingen, Department of Medical Informatics, G\u00f6ttingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Morris","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingya","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Medicine, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedram","family":"Fard","sequence":"additional","affiliation":[{"name":"Department of Medicine, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid V.","family":"Bassett","sequence":"additional","affiliation":[{"name":"Department of Medicine, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas S.","family":"Bell","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California, Los Angeles, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elmer V.","family":"Bernstam","sequence":"additional","affiliation":[{"name":"D. Bradley McWilliams School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam","family":"Visweswaran","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey G.","family":"Klann","sequence":"additional","affiliation":[{"name":"Department of Medicine, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn N.","family":"Murphy","sequence":"additional","affiliation":[{"name":"Department of Neurology, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Estiri","sequence":"additional","affiliation":[{"name":"Department of Medicine, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"issue":"1","key":"zoi260429r1","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12874-023-01839-2","article-title":"Data quality considerations for evaluating COVID-19 treatments using real world data: learnings from the National COVID Cohort Collaborative (N3C).","volume":"23","author":"Sidky","year":"2023","journal-title":"BMC Med Res Methodol"},{"issue":"5","key":"zoi260429r2","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1038\/s41591-023-02274-y","article-title":"Potential pitfalls in the use of real-world data for studying long COVID.","volume":"29","author":"Zhang","year":"2023","journal-title":"Nat Med"},{"key":"zoi260429r3","doi-asserted-by":"publisher","DOI":"10.2196\/59217","article-title":"Opportunities and challenges in using electronic health record systems to study postacute sequelae of SARS-CoV-2 infection: insights from the NIH RECOVER Initiative.","volume":"27","author":"Mandel","year":"2025","journal-title":"J Med Internet Res"},{"issue":"2","key":"zoi260429r4","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1172\/JCI129197","article-title":"Opportunities and challenges in using real-world data for health care.","volume":"130","author":"Rudrapatna","year":"2020","journal-title":"J Clin Invest"},{"issue":"1","key":"zoi260429r5","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/s12916-024-03477-x","article-title":"Healthcare utilisation in people with long COVID: an OpenSAFELY cohort study.","volume":"22","author":"Lin","year":"2024","journal-title":"BMC Med"},{"key":"zoi260429r6","doi-asserted-by":"publisher","DOI":"10.1177\/2150132721994040","article-title":"Race and ethnicity in real-world data sources: considerations for medical device regulatory efforts.","author":"Tarver","year":"2021","journal-title":"J Prim Care Community Health"},{"issue":"9","key":"zoi260429r7","doi-asserted-by":"publisher","DOI":"10.2196\/39235","article-title":"Issues with variability in electronic health record data about race and ethnicity: descriptive analysis of the National COVID Cohort Collaborative Data Enclave.","volume":"10","author":"Cook","year":"2022","journal-title":"JMIR Med Inform"},{"key":"zoi260429r8","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1474045","article-title":"Biases in COVID-19 vaccine effectiveness studies using cohort design.","volume":"11","author":"Agampodi","year":"2024","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"zoi260429r9","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1093\/ije\/dyac221","article-title":"Exploring the impact of selection bias in observational studies of COVID-19: a simulation study.","volume":"52","author":"Millard","year":"2023","journal-title":"Int J Epidemiol"},{"issue":"10350","key":"zoi260429r10","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/S0140-6736(22)01214-4","article-title":"Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study.","volume":"400","author":"Ballering","year":"2022","journal-title":"Lancet"},{"issue":"21","key":"zoi260429r11","doi-asserted-by":"publisher","first-page":"713","DOI":"10.15585\/mmwr.mm7121e1","article-title":"Post\u2013COVID conditions among adult COVID-19 survivors aged 18\u201364 and =65 years\u2014United States, March 2020\u2013November 2021.","volume":"71","author":"Bull-Otterson","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"zoi260429r12","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102210","article-title":"Characterization of long COVID temporal sub-phenotypes by distributed representation learning from electronic health record data: a cohort study.","volume":"64","author":"Dagliati","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"9","key":"zoi260429r13","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1093\/infdis\/jiac136","article-title":"Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or long COVID: a meta-analysis and systematic review.","volume":"226","author":"Chen","year":"2022","journal-title":"J Infect Dis"},{"issue":"8","key":"zoi260429r14","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1038\/s41591-022-01909-w","article-title":"Symptoms and risk factors for long COVID in non-hospitalized adults.","volume":"28","author":"Subramanian","year":"2022","journal-title":"Nat Med"},{"key":"zoi260429r15","doi-asserted-by":"publisher","DOI":"10.2196\/53445","article-title":"Characterization of post-COVID-19 definitions and clinical coding practices: longitudinal study.","volume":"16","author":"Maripuri","year":"2024","journal-title":"Online J Public Health Inform"},{"issue":"4","key":"zoi260429r16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2024.106235","article-title":"Prevalence, risk factors and characterisation of individuals with long COVID using electronic health records in over 1.5 million COVID cases in England.","volume":"89","author":"Wang","year":"2024","journal-title":"J Infect"},{"issue":"4","key":"zoi260429r17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1004194","article-title":"Prevalence and characteristics of long COVID in elderly patients: an observational cohort study of over 2 million adults in the US.","volume":"20","author":"Fung","year":"2023","journal-title":"PLoS Med"},{"key":"zoi260429r18","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101762","article-title":"The prevalence and long-term health effects of long Covid among hospitalised and non-hospitalised populations: a systematic review and meta-analysis.","volume":"55","author":"O\u2019Mahoney","year":"2022","journal-title":"EClinicalMedicine"},{"issue":"2","key":"zoi260429r19","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jinf.2023.12.004","article-title":"Persistence of post-COVID symptoms in the general population two years after SARS-CoV-2 infection: a systematic review and meta-analysis.","volume":"88","author":"Fernandez-de-Las-Pe\u00f1as","year":"2024","journal-title":"J Infect"},{"issue":"3","key":"zoi260429r20","doi-asserted-by":"publisher","DOI":"10.1016\/j.medj.2024.10.009","article-title":"Precision phenotyping for curating research cohorts of patients with unexplained post-acute sequelae of COVID-19.","volume":"6","author":"Azhir","year":"2025","journal-title":"Med"},{"issue":"2","key":"zoi260429r21","doi-asserted-by":"publisher","DOI":"10.1093\/jamiaopen\/ooab036","article-title":"Development of a coronavirus disease 2019 (COVID-19) application ontology for the Accrual to Clinical Trials (ACT) network.","volume":"4","author":"Visweswaran","year":"2021","journal-title":"JAMIA Open"},{"issue":"1","key":"zoi260429r22","doi-asserted-by":"publisher","DOI":"10.1017\/cts.2023.617","article-title":"The Evolve to Next-Gen ACT Network: an evolving open-access, real-world data resource primed for real-world evidence research across the Clinical and Translational Science Award Consortium.","volume":"7","author":"Morrato","year":"2023","journal-title":"J Clin Transl Sci"},{"issue":"2","key":"zoi260429r23","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/amiajnl-2011-000492","article-title":"A translational engine at the national scale: informatics for integrating biology and the bedside.","volume":"19","author":"Kohane","year":"2012","journal-title":"J Am Med Inform Assoc"},{"issue":"12","key":"zoi260429r25","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1093\/jamia\/ocad166","article-title":"A broadly applicable approach to enrich electronic-health-record cohorts by identifying patients with complete data: a multisite evaluation.","volume":"30","author":"Klann","year":"2023","journal-title":"J Am Med Inform Assoc"},{"key":"zoi260429r28","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jclinepi.2015.04.005","article-title":"Prediction models need appropriate internal, internal-external, and external validation.","volume":"69","author":"Steyerberg","year":"2016","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"zoi260429r29","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.jclinepi.2014.06.018","article-title":"A new framework to enhance the interpretation of external validation studies of clinical prediction models.","volume":"68","author":"Debray","year":"2015","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"zoi260429r30","first-page":"345","article-title":"From development to deployment: dataset shift, causality, and shift-stable models in health AI.","volume":"21","author":"Subbaswamy","year":"2020","journal-title":"Biostatistics"},{"issue":"27","key":"zoi260429r31","doi-asserted-by":"publisher","first-page":"7345","DOI":"10.1073\/pnas.1510507113","article-title":"Causal inference and the data-fusion problem.","volume":"113","author":"Bareinboim","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6464","key":"zoi260429r32","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1126\/science.aax2342","article-title":"Dissecting racial bias in an algorithm used to manage the health of populations.","volume":"366","author":"Obermeyer","year":"2019","journal-title":"Science"},{"issue":"6","key":"zoi260429r33","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1093\/cid\/ciaf046","article-title":"Long COVID incidence proportion in adults and children between 2020 and 2024: an electronic health record-based study from the RECOVER Initiative.","volume":"80","author":"Mandel","year":"2025","journal-title":"Clin Infect Dis"},{"issue":"1","key":"zoi260429r34","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1186\/s12889-025-22987-8","article-title":"Prevalence of and factors associated with long COVID among US adults: a nationwide survey.","volume":"25","author":"Shi","year":"2025","journal-title":"BMC Public Health"},{"issue":"2","key":"zoi260429r35","doi-asserted-by":"publisher","DOI":"10.1002\/pds.70101","article-title":"Lessons learned from characterizing long COVID among US Medicare beneficiaries.","volume":"34","author":"Lu","year":"2025","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"21","key":"zoi260429r37","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.3390\/healthcare13212704","article-title":"Long COVID is associated with excess direct healthcare expenditures among adults in the United States.","volume":"13","author":"Neba","year":"2025","journal-title":"Healthcare (Basel)"},{"issue":"11","key":"zoi260429r38","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1177\/01410768241288345","article-title":"Healthcare utilisation of 282,080 individuals with long COVID over two years: a multiple matched control, longitudinal cohort analysis.","volume":"117","author":"Mu","year":"2024","journal-title":"J R Soc Med"},{"issue":"22","key":"zoi260429r39","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1001\/jama.2023.8823","article-title":"Development of a definition of postacute sequelae of SARS-CoV-2 infection.","volume":"329","author":"Thaweethai","year":"2023","journal-title":"JAMA"},{"issue":"5","key":"zoi260429r40","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.cell.2022.01.014","article-title":"Multiple early factors anticipate post-acute COVID-19 sequelae.","volume":"185","author":"Su","year":"2022","journal-title":"Cell"},{"issue":"7985","key":"zoi260429r41","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41586-023-06651-y","article-title":"Distinguishing features of long COVID identified through immune profiling.","volume":"623","author":"Klein","year":"2023","journal-title":"Nature"},{"issue":"2","key":"zoi260429r42","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1136\/jamia.2009.000893","article-title":"Serving the enterprise and beyond with informatics for integrating biology and the bedside (i2b2).","volume":"17","author":"Murphy","year":"2010","journal-title":"J Am Med Inform Assoc"},{"key":"zoi260429r24","unstructured":"Agency for Healthcare Research and Quality; Healthcare Cost and Utilization Project. Clinical Classifications Software Refined (CCSR). Accessed October 27, 2023. https:\/\/hcup-us.ahrq.gov\/toolssoftware\/ccsr\/ccs_refined.jsp"},{"key":"zoi260429r26","doi-asserted-by":"crossref","unstructured":"H\u00fcgel? J, Sax? U, Murphy? SN, Estiri? H. tSPM+; a high-performance algorithm for mining transitive sequential patterns from clinical data.? arXiv. Preprint posted online September 8, 2023. doi:10.48550\/ARXIV.2309.05671","DOI":"10.3233\/SHTI240862"},{"key":"zoi260429r27","unstructured":"Clai Group. Long COVID AI scripts. Accessed April 20, 2026. https:\/\/github.com\/clai-group\/long_covid_ai_scripts"},{"key":"zoi260429r36","unstructured":"Centers for Disease Control and Prevention. Surveillance and data analytics: COVID. Accessed November 21, 2025. https:\/\/www.cdc.gov\/covid\/php\/surveillance\/index.html"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2849452\/tian_2026_oi_260429_1779136106.59756.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T15:30:32Z","timestamp":1779895832000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2849452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,27]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.14909","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,27]]}}}